Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.67 |
| ▸ | HPGD | P15428 | 1/20 | 0.67 |
| ▸ | TSHR | P16473 | 1/20 | 0.67 |
| ▸ | HTT | P42858 | 1/20 | 0.67 |
| ▸ | MMP13 | P45452 | 4/20 | 0.59 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.59 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.59 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.59 |
| ▸ | PLK1 | P53350 | 3/20 | 0.51 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.51 |
| ▸ | DEGS1 | O15121 | 2/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | MMP2 | P08253 | 1/20 | 0.46 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.46 |
| ▸ | NAMPT | P43490 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21628890 | 0.98 | SMN1; SMN2 (0.65) | SMN1; SMN2HPGDTSHRHTTMMP13 | |
| SCHEMBL21628615 | 0.98 | SMN1; SMN2 (0.65) | SMN1; SMN2HPGDTSHRHTTMMP13 | |
| SCHEMBL21628888 | 0.97 | SMN1; SMN2 (0.67) | SMN1; SMN2HPGDTSHRHTTMMP13 | |
| SCHEMBL21628388 | 0.94 | HPGD (0.71) | SMN1; SMN2HPGDTSHRHTTMMP13 | |
| SCHEMBL10283170 | 0.89 | HDAC8 (0.69) | SMN1; SMN2HPGDTSHRHTTHDAC8 | |
| SCHEMBL21628682 | 0.86 | HDAC6 (0.81) | SMN1; SMN2HPGDTSHRHTTMMP13 | |
| SCHEMBL21628811 | 0.85 | HDAC6 (0.79) | SMN1; SMN2MMP13HDAC8HDAC6HDAC1 | |
| SCHEMBL21628395 | 0.85 | HDAC6 (0.79) | SMN1; SMN2MMP13HDAC8HDAC6HDAC1 | |
| SCHEMBL17664589 | 0.84 | HDAC8 (0.59) | SMN1; SMN2HPGDTSHRHTTMMP13 | |
| SCHEMBL21628461 | 0.83 | HDAC8 (0.76) | SMN1; SMN2HPGDTSHRHTTMMP13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600696-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2026-04-14 | — | — | US | disclosed |
| US-20230406814-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2023-12-21 | — | — | US | disclosed |
| US-20230150923-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2023-05-18 | — | — | US | disclosed |
| US-11591289-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2023-02-28 | — | — | US | disclosed |
| US-11591289-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2023-02-28 | — | — | US | disclosed |
| US-20220348535-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2022-11-03 | — | — | US | disclosed |
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2021-04-15 | — | — | US | disclosed |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2020-01-30 | — | — | US | disclosed |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2020-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150923-A1 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | SMN1; SMN2 796/4885HPGD 2579/4885TSHR 3747/4885 |
| US-20220348535-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | SMN1; SMN2 796/4885HPGD 2579/4885TSHR 3747/4885 |
| US-11591289-B2 | Aromatic compounds | AHR, TYR, MUSK | SMN1; SMN2 1107/4885HPGD 2313/4885TSHR 3622/4885 |
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | SMN1; SMN2 796/4885HPGD 2579/4885TSHR 3747/4885 |
| US-12600696-B2 | Aromatic compounds | CCR1, CCRL2, AHR | SMN1; SMN2 919/4885HPGD 3694/4885TSHR 719/4885 |
| US-20230406814-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | SMN1; SMN2 796/4885HPGD 2579/4885TSHR 3747/4885 |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | SMN1; SMN2 796/4885HPGD 2579/4885TSHR 3747/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.